Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls; Guidance Document: Topical Oxygen Chamber for Extremities; Availability; Correction, 29251 [2011-12409]

Download as PDF Federal Register / Vol. 76, No. 98 / Friday, May 20, 2011 / Notices such as large print or Braille) should notify Genevieve Swift, PCPID Executive Administrative Assistant, via e-mail at Edith.Swift@acf.hhs.gov, or via telephone at 202–619–0634, no later than June 10, 2011. PCPID will attempt to meet requests for accommodations made after that date, but cannot guarantee ability to grant requests received after this deadline. All meeting sites are barrier free. Agenda: PCPID will meet to swear-in the new members of the Committee and set the agenda for the coming year. Additional Information: For further information, please contact Laverdia Taylor Roach, Director, President’s Committee for People with Intellectual Disabilities, The Aerospace Center, Second Floor West, 370 L’Enfant Promenade, SW., Washington, DC 20447. Telephone: 202–619–0634. Fax: 202–205–9519. E-mail: LRoach@acf.hhs.gov. PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services, through the Administration on Developmental Disabilities, on a broad range of topics relating to programs, services and supports for persons with intellectual disabilities. The PCPID Executive Order stipulates that the Committee shall: (1) Provide such advice concerning intellectual disabilities as the President or the Secretary of Health and Human Services may request; and (2) provide advice to the President concerning the following for people with intellectual disabilities: (A) Expansion of educational opportunities; (B) promotion of homeownership; (C) assurance of workplace integration; (D) improvement of transportation options; (E) expansion of full access to community living; and (F) increasing access to assistive and universally designed technologies. SUPPLEMENTARY INFORMATION: Dated: May 13, 2011. Sharon Lewis, Commissioner, Administration on Developmental Disabilities. [FR Doc. 2011–12508 Filed 5–19–11; 8:45 am] jlentini on DSK4TPTVN1PROD with NOTICES BILLING CODE 4184–01–P VerDate Mar<15>2010 17:22 May 19, 2011 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2006–D–0094] Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls; Guidance Document: Topical Oxygen Chamber for Extremities; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of April 25, 2011 (76 FR 22906). The document announced the availability of the guidance entitled ‘‘Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Documents: Topical Oxygen Chamber for Extremities.’’ The document published inadvertently with outdated information in the ADDRESSES, FOR FURTHER INFORMATION CONTACT, and Electronic Access sections. This document corrects those errors. FOR FURTHER INFORMATION CONTACT: Charles N. Durfor, Center for Devices and Radiological Health, 10903 New Hampshire Ave., Bldg. 66, Rm. G424, Silver Spring, MD 20993–0002, 301– 796–6438. SUPPLEMENTARY INFORMATION: In FR Doc. 2011–9898, appearing on page 22906, in the Federal Register of Monday, April 25, 2011, the following corrections are made: 1. On page 22906, in the first column, correct the ADDRESSES caption to read: ADDRESSES: Submit written request for single copies of the guidance document entitled ‘‘Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities’’ to the Division of Small Manufacturers, International, and Consumer Assistance, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 4613, Silver Spring, MD 20993–0002. Send one self-addressed adhesive label to assist that office in processing your request, or fax your request to 301–847– 8149. See the SUPPLEMENTARY INFORMATION section for information on electronic access to the guidance. Submit electronic comments on the guidance to https://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 2. On page 22906, in the second column, correct the FOR FURTHER INFORMATION CONTACT caption to read: FOR FURTHER INFORMATION CONTACT: Charles N. Durfor, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. G424, Silver Spring, MD 20993–0002, 301–796–6438. 3. On page 22906, in the third column, correct the Electronic Access caption to read: III. Electronic Access Notice; correction. SUMMARY: 29251 Persons interested in obtaining a copy of the guidance may do so by using the Internet. A search capability for all CDRH guidance documents is available at https://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ GuidanceDocuments/default.htm. Guidance documents are available at https://www.regulations.gov. To receive ‘‘Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities’’ you may send an e-mail request to dismica@fda.hhs.gov to receive an electronic copy of the document or send a fax request to 301– 847–8149 to receive a hard copy. Please use the document number 1582 to identify the guidance you are requesting. Dated: May 17, 2011. Nancy K. Stade, Deputy Director for Policy, Center for Devices and Radiological Health. [FR Doc. 2011–12409 Filed 5–19–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Proposed Collection: Comment Request In compliance with the requirement for opportunity for public comment on proposed data collection projects (section 3506(c)(2)(A) of Title 44, United States Code, as amended by the Paperwork Reduction Act of 1995, Pub. L. 104–13), the Health Resources and Services Administration (HRSA) publishes periodic summaries of proposed projects being developed for submission to the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, e-mail paperwork@hrsa.gov or call the HRSA E:\FR\FM\20MYN1.SGM 20MYN1

Agencies

[Federal Register Volume 76, Number 98 (Friday, May 20, 2011)]
[Notices]
[Page 29251]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12409]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2006-D-0094]


Guidance for Industry and Food and Drug Administration Staff; 
Class II Special Controls; Guidance Document: Topical Oxygen Chamber 
for Extremities; Availability; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of April 25, 2011 (76 FR 22906). 
The document announced the availability of the guidance entitled 
``Guidance for Industry and Food and Drug Administration Staff; Class 
II Special Controls Guidance Documents: Topical Oxygen Chamber for 
Extremities.'' The document published inadvertently with outdated 
information in the ADDRESSES, FOR FURTHER INFORMATION CONTACT, and 
Electronic Access sections. This document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Charles N. Durfor, Center for Devices 
and Radiological Health, 10903 New Hampshire Ave., Bldg. 66, Rm. G424, 
Silver Spring, MD 20993-0002, 301-796-6438.

SUPPLEMENTARY INFORMATION: In FR Doc. 2011-9898, appearing on page 
22906, in the Federal Register of Monday, April 25, 2011, the following 
corrections are made:
    1. On page 22906, in the first column, correct the ADDRESSES 
caption to read: ADDRESSES: Submit written request for single copies of 
the guidance document entitled ``Class II Special Controls Guidance 
Document: Topical Oxygen Chamber for Extremities'' to the Division of 
Small Manufacturers, International, and Consumer Assistance, Center for 
Devices and Radiological Health, Food and Drug Administration, 10903 
New Hampshire Ave., Bldg. 66, Rm. 4613, Silver Spring, MD 20993-0002. 
Send one self-addressed adhesive label to assist that office in 
processing your request, or fax your request to 301-847-8149. See the 
SUPPLEMENTARY INFORMATION section for information on electronic access 
to the guidance.
    Submit electronic comments on the guidance to https://www.regulations.gov. Submit written comments to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852.
    2. On page 22906, in the second column, correct the FOR FURTHER 
INFORMATION CONTACT caption to read:

FOR FURTHER INFORMATION CONTACT: Charles N. Durfor, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, rm. G424, Silver Spring, MD 20993-0002, 301-
796-6438.
    3. On page 22906, in the third column, correct the Electronic 
Access caption to read:

III. Electronic Access

    Persons interested in obtaining a copy of the guidance may do so by 
using the Internet. A search capability for all CDRH guidance documents 
is available at https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm. Guidance 
documents are available at https://www.regulations.gov. To receive 
``Class II Special Controls Guidance Document: Topical Oxygen Chamber 
for Extremities'' you may send an e-mail request to dismica@fda.hhs.gov 
to receive an electronic copy of the document or send a fax request to 
301-847-8149 to receive a hard copy. Please use the document number 
1582 to identify the guidance you are requesting.

    Dated: May 17, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices and Radiological Health.
[FR Doc. 2011-12409 Filed 5-19-11; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.